Ambit
Driving breakthroughs in cancer and inflammatory disease treatment through pioneering kinase inhibitor research and innovative clinical collaborations.
General Information
BounceWatch is an independent company data service, not affiliated with Ambit. To contact Ambit, visit ambitbio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Ambit compare?
A PDF of Ambit and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Ambit soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
About Ambit
Business keywords: biopharmaceutical, kinase inhibitors, cancer treatment, inflammatory disease, clinical trials, FLT3 inhibitor, oncology, Astellas Pharma Inc., small molecule drugs, AC220, AC480, AC430, JAK2 inhibitor, preclinical pipeline, drug discovery
Funding Rounds & Investors (10)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Venture Round | $50.00M | 9 |
|
06 Nov 2012 |
| Series D | $30.00M | 9 |
|
10 Jun 2011 |
| Debt Financing | $15.00M | - |
|
15 Oct 2010 |
| Series D | $12.00M | - |
|
15 Apr 2010 |
| Debt Financing | $6.43M | - |
|
05 Jun 2009 |
| Series D | $49.30M | 10 |
|
14 Nov 2007 |
| Series C | $31.00M | 7 |
|
12 May 2005 |
| Venture Round | $1.20M | - |
|
23 Oct 2003 |
| Series B | $18.80M | 3 |
|
31 Dec 2000 |
| Seed Round | $2.00M | - |
|
01 Dec 2000 |
Ambit Alternatives & Competitors
View All Alternatives
Pioneering novel therapies with promising small molecule kinase inhibitors for a brighter future in...
Pioneering the future of kinase inhibitors through innovative drug design and strategic collaboratio...
Innovating patient care with advanced small molecule therapies for severe medical conditions, includ...
FAQ About Ambit
Source: BounceWatch company record for Ambit, https://bouncewatch.com/company/ambit-biosciences, updated 24 October 2024. When citing, please name BounceWatch and link this page.
